A Pharmaceutical giant, Wellcome and the Bill & Melinda Gates Foundation have announced funding, to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical trial.
Trending
- Sokoto locks down ADC office over ownership dispute
- Farmers seek relief from soaring poultry costs
- OGFTZ infrastructure supports 35,000 jobs
- Enugu highlights push to industrialise agriculture
- Kyari defends govt response to food insecurity
- Google offers Nigerians offline AI skills training
- WHO says pathogen-sharing deal Is key to pandemic readiness
- Wamakko emerges inaugural winner of Sultan Abubakar III Award for Exemplary Leadership
